The role of recombinant activated factor VII in cardiac surgery

Recombinant factor VIIa may reduce surgical blood loss and transfusion of blood products in cardiac surgery. However, the true risks of its use in this setting remains to be elucidated, especially when it is administered with other potent pro-haemostatic agents. We reviewed the recent literature on...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, A, Herbertson, M, Gill, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDIMES Edizioni Internazionali Srl 2009
Materias:
Brief-Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484551/
https://www.ncbi.nlm.nih.gov/pubmed/23439927

Ejemplares similares

Ejemplares similares